MedPath

济南辰欣医药科技有限公司

Ownership
-
Established
2020-07-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H20254512
Approval Date
Jun 10, 2025
NMPA

Mepivacaine Hydrochloride Injection

Product Name
盐酸甲哌卡因注射液
Approval Number
国药准字H20249473
Approval Date
Dec 1, 2024
NMPA

Calcium Gluconate Injection

Product Name
葡萄糖酸钙注射液
Approval Number
国药准字H20244921
Approval Date
Sep 19, 2024
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20233291
Approval Date
Mar 21, 2023
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20055277
Approval Date
May 9, 2020
NMPA

Bromfenac Sodium Eye Drops

Product Name
溴芬酸钠滴眼液
Approval Number
国药准字H20150022
Approval Date
Mar 3, 2020
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath